Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

randomized controlled trials

  • You have accessRestricted Access
    In Search of the Optimal Target for Phosphate Control: Episode 1
    Ron Wald and Michael W. Walsh
    JASN March 2021, 32 (3) 526-528; DOI: https://doi.org/10.1681/ASN.2021010027
    Add to Selected Citations
  • Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
    You have accessRestricted Access
    Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
    Steven Fishbane, Mohamed A. El-Shahawy, Roberto Pecoits-Filho, Bui Pham Van, Mark T. Houser, Lars Frison, Dustin J. Little, Nicolas J. Guzman and Pablo E. Pergola
    JASN March 2021, 32 (3) 737-755; DOI: https://doi.org/10.1681/ASN.2020081150
    Add to Selected Citations
  • You have accessRestricted Access
    Authors’ Reply
    Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, Yoshikatsu Majikawa and Michael Reusch
    JASN November 2020, 31 (11) 2738-2740; DOI: https://doi.org/10.1681/ASN.2020071096
    Add to Selected Citations
  • You have accessRestricted Access
    Pilot Trials in Nephrology: Establishing a BASE for Large-Scale Randomized Trials
    Brendon L. Neuen and Vlado Perkovic
    JASN January 2020, 31 (1) 4-6; DOI: https://doi.org/10.1681/ASN.2019111196
    Add to Selected Citations
  • GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
    You have accessRestricted Access
    GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
    Lesley A. Inker, Hiddo J. L. Heerspink, Hocine Tighiouart, Andrew S. Levey, Josef Coresh, Ron T. Gansevoort, Andrew L. Simon, Jian Ying, Gerald J. Beck, Christoph Wanner, Jürgen Floege, Philip Kam-Tao Li, Vlado Perkovic, Edward F. Vonesh and Tom Greene
    JASN September 2019, 30 (9) 1735-1745; DOI: https://doi.org/10.1681/ASN.2019010007
    Add to Selected Citations
  • You have accessRestricted Access
    The Case for Selective Withdrawal of Antidepressants in Patients with Advanced Kidney Disease
    Joseph Chilcot and Ken Farrington
    JASN July 2019, 30 (7) 1339-1340; DOI: https://doi.org/10.1681/ASN.2019030308
    Add to Selected Citations
  • You have accessRestricted Access
    Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers
    Wing-Chi G. Yeung, Nigel D. Toussaint and Sunil V. Badve
    JASN June 2019, 30 (6) 909-910; DOI: https://doi.org/10.1681/ASN.2019040333
    Add to Selected Citations
  • Open Access
    Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era
    Rohit Maini, David B. Wong, Daniel Addison, Elizabeth Chiang, Steven D. Weisbord and Hani Jneid
    JASN December 2018, 29 (12) 2782-2786; DOI: https://doi.org/10.1681/ASN.2018070674
    Add to Selected Citations
  • Open Access
    Translational Methods in Nephrology: Individual Treatment Effect Modeling
    F. Perry Wilson and Chirag R. Parikh
    JASN November 2018, 29 (11) 2615-2618; DOI: https://doi.org/10.1681/ASN.2018060629
    Add to Selected Citations
  • Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
    You have accessRestricted Access
    Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
    Christoph Wanner, Hiddo J.L. Heerspink, Bernard Zinman, Silvio E. Inzucchi, Audrey Koitka-Weber, Michaela Mattheus, Stefan Hantel, Hans-Juergen Woerle, Uli C. Broedl, Maximilian von Eynatten, Per-Henrik Groop and on behalf of the EMPA-REG OUTCOME Investigators
    JASN November 2018, 29 (11) 2755-2769; DOI: https://doi.org/10.1681/ASN.2018010103
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire